UroGen Pharma
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $25,204 | $21,848 | $18,781 | $23,530 |
Gross Profit | 22,751 | 19,619 | 17,053 | 21,244 |
EBITDA | -14,680 | -25,576 | -25,389 | -14,185 |
EBIT | -14,946 | -25,839 | -25,740 | -14,609 |
Net Income | -23,673 | -33,403 | -32,286 | -26,016 |
Net Change In Cash | 25,204 | 21,848 | 18,781 | 23,530 |
Free Cash Flow | -27,760 | -23,832 | -31,735 | -13,109 |
Cash | 124,916 | 220,797 | 132,262 | 95,823 |
Basic Shares | 43,100 | 36,821 | 33,379 | 36,153 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $82,713 | $64,357 | $48,042 | $11,799 |
Gross Profit | 73,352 | 56,703 | 42,885 | 10,790 |
EBITDA | -63,831 | -78,031 | -90,154 | -124,695 |
EBIT | -65,536 | -79,848 | -91,927 | -126,739 |
Net Income | -102,244 | -109,163 | -110,820 | -128,484 |
Net Change In Cash | 82,713 | 64,357 | 48,042 | 11,799 |
Cost of Revenue | 10,635 | -8,504 | 3,879 | |
Free Cash Flow | -76,570 | -87,813 | -85,644 | -107,101 |
Cash | 95,002 | 55,408 | 44,360 | 103,911 |
Basic Shares | 28,834 | 22,806 | 22,347 | 21,780 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.55 |
2024-06-30 | -$0.91 |
2024-03-31 | -$0.97 |
2023-12-31 | -$0.72 |
